Effects of RG1068 (Secretin) on Information Processing in Schizophrenia
NCT00235274
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Subcutaneous Secretin
Sponsor
Indiana University
Collaborators
[object Object]
[object Object]